<http://webisa.webdatacommons.org/124286505>	<http://www.w3.org/ns/prov#value>	"???Multiple sclerosis is a debilitating disease for which there are currently few treatments,??? said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. ???We hope our fully human antibody, ofatumumab, may offer another potential treatment option for patients suffering from this incapacitating disease.???" .
<http://webisa.webdatacommons.org/124286505>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<thisisms.com> .
<http://webisa.webdatacommons.org/prov/26769958>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/124286505> .
<http://webisa.webdatacommons.org/124286505>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .